Metronomic Treatment in Children and Adolescents With Recurrent or Progressive High Risk Neuroblastoma
NCT02641314
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Recurrent Neuroblastoma
Interventions
DRUG:
metronomic therapy
Sponsor
University of Cologne